Multifunctional Liquid Crystal Nanoparticles for Cancer Therapy

Author(s): Abhishesh K. Mehata*, Deepa Dehari, Amit Gupta, Dangali C. Rabin, Alim Miya

Journal Name: Current Nanomaterials

Volume 6 , Issue 1 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Cancer is the second foremost reason for worldwide death, affecting every country of the globe. However, 70% of cancer-related death was reported from low- and middle-income nations. Delay in the detection and intervention of therapeutic agents in cancer patients also promoted a cancer-related mortality index. Currently, numerous nanomedicines are under development for advancing tumor diagnosis and therapeutic capability. Recently, liquid crystalline nanoparticles (LCNPs) have emerged as an attractive drug delivery system for both intravenous and non-intravenous applications. The widely explored LCNPs for cancer therapy include cubosomes and hexosomes. They have significant advantages over other drug delivery system, which includes, high internal surface area, unique solubilization properties and sustained release of entrapped drug molecules and co-loading of imaging and therapeutic agents in a single system. In this review, we have briefly discussed the advantages of LCNPs, preparation methods, and their multifunctional role in treating various cancers.

Keywords: Cancer, cubosomes, hexosomes, liquid crystalline nanoparticles, theranostics, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 17 January, 2021
Page: [4 - 16]
Pages: 13
DOI: 10.2174/2405461506666210118114851
Price: $65

Article Metrics

PDF: 14